TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Life Healthcare Group ( (HK:0928) ) has shared an update.
King International Investment Limited has announced the formation of a joint venture with several partners in the PRC, focusing on the development of a new Superoxide Dismutase (SOD) business segment. This strategic move aims to leverage the company’s resources and expertise to enhance operational efficiency and product marketing, thereby promoting growth in the biopharmaceutical sector. The SOD segment, with its unique scientific properties and intellectual property barriers, is expected to open new growth opportunities in high-end medical aesthetics, functional foods, and specialized medical applications, empowering the company’s existing consumer businesses and building a technology-driven valuation system.
More about Life Healthcare Group
King International Investment Limited, formerly known as Life Healthcare Group Limited, operates in the healthcare industry with a focus on biopharmaceuticals. The company is involved in developing innovative healthcare solutions, particularly in the field of synthetic biology and biotechnology, aiming to enhance its market presence and expand its product offerings.
Average Trading Volume: 6,677,326
Technical Sentiment Signal: Buy
Current Market Cap: HK$173.9M
See more data about 0928 stock on TipRanks’ Stock Analysis page.